Wockhardt
WOCKPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Habil Khorakiwala · MD: Murtaza Khorakiwala · Listing date: Feb. 23, 2000 · Employees: 5000 · Mumbai · http://www.wockhardt.com

Stock Price vs Company Growth
1d
3.5%
1w
-0.0%
1m
10.7%
3m
12.6%
6m
85.8%
1y
63.8%
5y
40.3%
10y
10.3%
all
10.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,187 3.5%
1,792
2,360
Company Overview

Sales
3,564 Cr
Growth: 8.6%
Profit after Tax
387 Cr
Growth: 102.6%
Large Cap
35,540 Cr
P/E: 86.8x
Industry P/E: 35.1x
Fundamentals

Sales (Cr) ₹ 3,564
Growth 8.6%
EBITDA 21.7%
P/S 10.0x
Dividend 0.0%
P/E 86.8x
Book Value ₹ 311
PEG Ratio 10.5x
ROE 8.3%
P/B 7.3x
Shareholding Pattern

Institutions
Promoters
Themisto Trustee Company Private Limited
54.16 %
Themisto Trustee Company Private Limited
3.43 %
Pasithee Trustee Company Private Limited
3.07 %
Ananke Trustee Company Private Limited
2.89 %
Callirhoe Trustee Company Private Limited
2.89 %
Others
Jhunjhunwala Rakesh Radheshyam
2.26 %
Iepf
0.18 %
Increase    Decrease    No change
Company Profile Detailed

The company is a pharmaceutical and biotechnology company. The company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Businesses of the companyNew drug discoveryBranded pharmaceuticalsContract manufacturingBiologicals in diabetesVaccinesAPIAwards2009Outstanding National Citizen Award by National Citizens Guild.Strathmore’s Who’s Who - Social Entrepreneur of the Year.
Investors (118)
Followers (7)